High Bone Sialoprotein (BSP) Expression Correlates with Increased Tumor Grade and Predicts a Poorer Prognosis of High-Grade Glioma Patients

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Xu, Tao ^a   Qin, Rong ^a   Zhou, Jinxu ^a   Yan, Yong ^a   Lu, Yicheng ^a   Zhang, Xiaoping ^b,c   Fu, Da ^b,c   Lv, Zhongwei ^b,c   Li, Weiqing ^a   Xia, Chunyan ^a   Hu, Guohan ^a   Ding, Xuehua ^a   Chen, Juxiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

6 O METHYLGUANINE; BONE SIALOPROTEIN; DNA METHYLTRANSFERASE; MESSENGER RNA;

ADULT; AGED; ARTICLE; ASTROCYTE; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CELL LINEAGE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA METHYLATION; FEMALE; GENE OVEREXPRESSION; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY;

AGED; BRAIN NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; INTEGRIN-BINDING SIALOPROTEIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84868315316     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048415     Document Type: Article

References (27)

1. Wen PY, Kesari S, (2008) Malignant gliomas in adults. N Engl J Med 359: 492-507.
2. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, et al. (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193.
3. Hegi ME, Liu L, Herman JG, Stupp R, Wick W, et al. (2008) Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26: 4189-4199.
4. Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, et al. (2011) Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin. J Clin Oncol 29: 4482-4490.
5. Bellahcene A, Merville MP, Castronovo V, (1994) Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res 54: 2823-2826.
6. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, et al. (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25: 2586-2593.
7. Yang GH, Fan J, Xu Y, Qiu SJ, Yang XR, et al. (2008) Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. Oncologist 13: 1155-1165.
8. Bellahcene A, Castronovo V, Ogbureke KU, Fisher LW, Fedarko NS, (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 8: 212-226.
9. Waltregny D, Bellahcene A, Van Riet I, Fisher LW, Young M, et al. (1998) Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst 90: 1000-1008.
10. Papotti M, Kalebic T, Volante M, Chiusa L, Bacillo E, et al. (2006) Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study. J Clin Oncol 24: 4818-4824.
11. Tu Q, Zhang J, Fix A, Brewer E, Li YP, et al. (2009) Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells. J Cell Physiol 218: 135-145.
12. Zhang JH, Wang J, Tang J, Barnett B, Dickson J, et al. (2004) Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells. Anticancer Res 24: 1361-1368.
13. Nam JS, Suchar AM, Kang MJ, Stuelten CH, Tang B, et al. (2006) Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer. Cancer Res 66: 6327-6335.
14. Riminucci M, Corsi A, Peris K, Fisher LW, Chimenti S, et al. (2003) Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis, Cbfa1/Runx2, in malignant melanoma. Calcif Tissue Int 73: 281-289.
15. Kayed H, Kleeff J, Keleg S, Felix K, Giese T, et al. (2007) Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Cancer Lett 245: 171-183.
16. Valabrega G, Fagioli F, Corso S, Madon E, Brach dPA, et al. (2003) ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells. Br J Cancer 88: 396-400.
17. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847.
18. Barnholtz-Sloan JS, Williams VL, Maldonado JL, Shahani D, Stockwell HG, et al. (2008) Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 108: 642-648.
19. Pignatti F, den Bent M v, Curran D, Debruyne C, Sylvester R, et al. (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20: 2076-2084.
20. den Bent MJ v (2007) Anaplastic oligodendroglioma and oligoastrocytoma. Neurol Clin 25: 1089-1109, ix-x.
21. Mukerji N, Rodrigues D, Hendry G, Dunlop PR, Warburton F, et al. (2008) Treating high grade gliomas in the elderly: the end of ageism. J Neurooncol 86: 329-336.
22. Schomas DA, Laack NN, Rao RD, Meyer FB, Shaw EG, et al. (2009) Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol 11: 437-445.
23. Fedarko NS, Jain A, Karadag A, Fisher LW, (2004) Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J 18: 734-736.
24. Fisher LW, Jain A, Tayback M, Fedarko NS, (2004) Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers. Clin Cancer Res 10: 8501-8511.
25. Bellahcene A, Bonjean K, Fohr B, Fedarko NS, Robey FA, et al. (2000) Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 86: 885-891.
26. Diel IJ, Solomayer EF, Seibel MJ, Pfeilschifter J, Maisenbacher H, et al. (1999) Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res 5: 3914-3919.
27. Jung K, Lein M, Stephan C, Von Hosslin K, Semjonow A, et al. (2004) Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. Int J Cancer 111: 783-791.